BioSpace News Archive

VolitionRx Limited today announced results from its first proof of concept study conducted by Texas A&M University.

Medical Diagnostic Laboratories, L.L.C., (MDL) , a Genesis Biotechnology Group ® (GBG) company and CLIA-certified, CAP-accredited laboratory specializing in high-complexity, state-of-the-art, automated DNA-based molecular analyses, has expanded its testing to include an antibody detection assay for SARS-CoV-2 (COVID-19). Cor

- New animated video, “Together, We Can Solve the Parkinson’s Puzzle,” aims to encourage Parkinson’s patients and families to take part in research to help speed a cure - Narrated by Emmy- and Golden Globe-winning actor Alan Alda, the video can be watched at michaeljfox.org/your-role-research - Content made possible by ACADIA Pharmaceuticals, with additional funding from members of MJFF’s Parkinson’s Disease Education Consortium

Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of cancer and other life-threatening diseases, today announced that Chimerix, Inc., to whom it licensed worldwide rights for the development and commercialization of its lead product, CX-01 (now known as DS

CytRx Eligible to Receive up to $120 Million in Future Milestones, Plus Single and Double-Digit Royalties, From the Sales of Arimoclomol

Transplant Genomics, Inc. (“TGI”), announce that Dr. Peter Meintjes will join the company as Chief Commercial Officer to lead the commercialization of TruGraf®, the only blood test approved by CMS for surveillance to rule out “silent” subclinical acute rejection in kidney transplant recipients with stable graft function.

Prealize, an artificial intelligence (AI)-enabled health insights company, today announced that, for the second straight year, it was selected as a winner of the Innovation in Healthcare Analytics Award, presented as part of the 2020 MedTech Breakthrough Awards program

Now available - On-demand webinar for ALS families on how to manage stress during COVID-19 pandemic May 1 , 3 p.m. ET - Facebook Live @MDAorg with leading ALS expert Dr. Matthew Harms May 1

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31, 2020 , after the market close on May 6, 2020 . Natera will host a conference call and webcast at 1:30 p.m. PT ( 4:30 p.m. ET ) to discuss its financial resu

Precision Spine ® Announces the National Launch of the ShurFit ® 2C Interbody Systems Featuring Titanium Plasma Spray and Hydroxyapatite Coating PARSIPPANY, N.J.--( BUSINESS WIRE )-- Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, has launched nationally the ShurFit ® ACIF 2C Anterior Cervical, TLIF 2C and TPLIF 2C Posterior Interbody Systems, which is made from medical grade polyetheretherketone (Peek Optima,